011040 — Kyungdong Pharm Share Price
0.000.00%
Last trade - 00:00- KR₩187bn
- KR₩203bn
- KR₩163bn
- 57
- 59
- 75
- 75
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.87 | ||
| Price to Tang. Book | 0.89 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.1 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.6% | ||
| Return on Equity | -8.16% | ||
| Operating Margin | -12.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 176,500.19 | 173,827.66 | 177,610.83 | 182,718.16 | 162,674.1 | n/a | n/a | -1.93% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +119.08 | +1.93 | -9.57 | +0.94 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KYUNG DONG PHARMACEUTICAL CO.,LTD. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Company’s products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. It also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.
Directors
- Deok Hui Ryu CHM (83)
- Gi Seong Ryu CCE (31)
- Hyeong Jun Gil OTH (54)
- Jae Bok Lee OTH (73)
- Seong Ja Lee OTH (69)
- Byeong Jo Park OTH (52)
- Won Gyo Park OTH (50)
- Yun Seop Shin OTH (54)
- Dong Ok Cha NID (59)
- Sun Bo Lee NID (69)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- February 12th, 1976
- Public Since
- December 18th, 1992
- No. of Shareholders
- 15,014
- No. of Employees
- 588
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 26,941,770
- Address
- 224-3, Jeyakdanji-ro, Yanggam-myeon, HWASEONG, 18631
- Web
- https://www.kdpharma.co.kr/
- Phone
- +82 313520990
- Auditors
- DaeSung SamKyung Accounting Corporation
Upcoming Events for 011040
Similar to 011040
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
What is the Kyungdong Pharm share price?
As of Today at 01:39 UTC, shares in Kyungdong Pharm are trading at KR₩6,950. This share price information is delayed by 15 minutes.
How has the Kyungdong Pharm share price performed this year?
Shares in Kyungdong Pharm last closed at KR₩6,950 and the price had moved by +3.13% over the past 365 days. In terms of relative price strength the Kyungdong Pharm share price has underperformed the FTSE Developed Asia Pacific Index by -4.9% over the past year.
What are the analyst and broker recommendations for Kyungdong Pharm?
The overall consensus recommendation for Kyungdong Pharm is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Kyungdong Pharm dividend yield?
The Kyungdong Pharm dividend yield is 5.76% based on the trailing twelve month period.
Does Kyungdong Pharm pay a dividend?
Last year, Kyungdong Pharm paid a total dividend of KR₩400, and it currently has a trailing dividend yield of 5.76%. We do not have any data on when Kyungdong Pharm is to next pay dividends.
When does Kyungdong Pharm next pay dividends?
We do not have data on when Kyungdong Pharm is to next pay dividends. The historic dividend yield on Kyungdong Pharm shares is currently 5.76%.
How do I buy Kyungdong Pharm shares?
To buy shares in Kyungdong Pharm you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kyungdong Pharm?
As of the previous close price of KR₩6,950, shares in Kyungdong Pharm had a market capitalisation of KR₩187bn.
Where are Kyungdong Pharm shares listed?
Here are the trading details for Kyungdong Pharm:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 011040
What kind of share is Kyungdong Pharm?
Based on an overall assessment of its quality, value and momentum Kyungdong Pharm is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kyungdong Pharm share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Kyungdong Pharm share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kyungdong Pharm. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +5.85%.
As of the last closing price of KR₩6,950, shares in Kyungdong Pharm were trading +6.21% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kyungdong Pharm PE Ratio?
The Kyungdong Pharm PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩6,950.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kyungdong Pharm?
Kyungdong Pharm's management team is headed by:
- Deok Hui Ryu - CHM
- Gi Seong Ryu - CCE
- Hyeong Jun Gil - OTH
- Jae Bok Lee - OTH
- Seong Ja Lee - OTH
- Byeong Jo Park - OTH
- Won Gyo Park - OTH
- Yun Seop Shin - OTH
- Dong Ok Cha - NID
- Sun Bo Lee - NID